omniture
logo
Search
DeepQure
Media Room

Latest News

rss

DeepQure Strengthens Clinical Leadership with Former SoniVie Executive Appointment

SEOUL, South Korea, Sept. 2, 2025 /PRNewswire/ -- DeepQure, a company pioneering a paradigm shift i...

2025-09-03 10:52 1633

MFDS Clears DeepQure's HyperQure™ for Clinical Trial in Atrial Fibrillation

SEOUL, South Korea, July 17, 2025 /PRNewswire/ -- DeepQure announced today that South Korea's Minis...

2025-07-18 10:59 1609

DeepQure Advances Global Clinical Trials for Innovative RDN Technology

SEOUL, South Korea, March 3, 2025 /PRNewswire/ -- Breaking Barriers in Hypertension Treatment DeepQ...

2025-03-04 09:46 1854

DeepQure Presents Clinical Results of Laparoscopic RDN at TCT 2024, Demonstrating Cutting-edge Technology and Innovation

SEOUL, South Korea, Oct. 29, 2024 /PRNewswire/ -- DeepQure, a global pioneer in resistant hypertens...

2024-10-29 21:00 1976

DeepQure receives IDE Approval from FDA for its EFS study to treat Resistant Hypertension with its Extravascular Renal Denervation Technology (HyperQure™)

SEOUL, South Korea, June 10, 2024 /PRNewswire/ -- DeepQure, a Seoul based medical device company wi...

2024-06-10 13:14 2147
DeepQure receives IDE Approval from FDA for its EFS study to treat Resistant Hypertension with its Extravascular Renal Denervation Technology (HyperQure™)